News-Medical.Net on MSN13d
Understanding the role of LSD1 in cellular processes and disease
A new review highlights the pivotal role of LSD1 (lysine-specific demethylase 1) in regulating critical cellular processes ...
EurekAlert!14d
New insights into LSD1: a key regulator in disease pathogenesis
A new review highlights the pivotal role of LSD1 (lysine-specific demethylase 1) in regulating critical cellular processes ...
pharmaphorum4d
Exscientia builds cancer pipeline with two BMS drugs
The two new compounds – LSD1 inhibitor EXS74539 and MALT1 protease inhibitor EXS73565 – both hit targets in cancer that have proved challenging for other drug developers, mainly as a result of ...
Morningstar7d
ORYZON to Provide Corporate Progress Updates at Several Events in March-April
Beyond hematological cancers, the inhibition of LSD1 has been proposed as a valid therapeutic approach in some solid tumors such as small cell lung cancer (SCLC), neuroendocrine tumors (NET ...
pharmaphorum2y
Merck bulks up in haematology, buying Imago for $1.35bn
Bomedemstat (IMG-7289) – an oral lysine-specific demethylase 1 (LSD1) inhibitor – is in multiple phase 2 trials for the treatment of indications including essential thrombocythemia (ET ...